CIK 0001768224 · Accelerated filer<br>Smaller reporting company
Arcturus Therapeutics Holdings Inc.
Sign in to watch- Ticker
- ARCT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 8589002660
- Business address
- 10285 SCIENCE CENTER DRIVE, SAN DIEGO, CA
- 4 Open-market sale Chief Scientific Officer & COO sold 10,000 shares at $75.31 ($753,100)
- 8-K Event New debt or obligation
- SC 13G Stake Amended Statement of Ownership
- SC 13G Stake Amended Statement of Ownership
- 4 Open-market sale Chief Scientific Officer & COO sold 10,000 shares at $46.40 ($464,000)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Director sold 800,000 shares at an average $100.81 ($80,650,635)
- SC 13D/A Stake Beneficial Ownership Report
- 424B5 Offering Prospectus
- 8-K Event Material agreement · Regulation FD disclosure
- 424B5 Offering Prospectus
- S-3ASR Offering Registration Statement
- 8-K Event Material agreement
- 4 Open-market sale Chief Scientific Officer & COO sold 10,000 shares at $96.19 ($961,900)
- 8-K Event Bylaws or fiscal year change
Page 15 of 21 · 416 filings